Anthera Pharmaceuticals, Inc. — Net Income by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/46b78cba-8aa7-4646-a04e-2f5546eed1cd/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2017 | $-26.9M | 2017-01-01 – 2017-12-31 | evidence 0001214659-18-001789 |
| FY 2016 | $-55.5M | 2016-01-01 – 2016-12-31 | evidence 0001214659-17-002018 |
| FY 2015 | $-35.2M | 2015-01-01 – 2015-12-31 | evidence 0001214659-16-010295 |
| FY 2014 | $-29.6M | 2014-01-01 – 2014-12-31 | evidence 0001214659-15-002302 |
| FY 2013 | $-295.1M | 2004-09-10 – 2014-03-31 | evidence 0001214659-14-003584 |
| FY 2012 | $-268.0M | 2004-09-09 – 2013-03-31 | evidence 0001214659-13-002660 |
| FY 2011 | $-99.1M | 2011-01-01 – 2011-12-31 | evidence 0001214659-14-002323 |
| FY 2010 | $-46.7M | 2010-01-01 – 2010-12-31 | evidence 0001214659-14-002323 |
| FY 2009 | $-12.2M | 2009-01-01 – 2009-12-31 | evidence 0001214659-13-001633 |
| FY 2008 | $-18.1M | 2008-01-01 – 2008-12-31 | evidence 0001214659-13-001633 |
| FY 2007 | $-25.7M | 2007-01-01 – 2007-12-31 | evidence 0001214659-13-001633 |
| FY 2006 | $-8.7M | 2006-01-01 – 2006-12-31 | evidence 0001214659-13-001633 |
| FY 2005 | $-554.0k | 2004-09-10 – 2005-12-31 | evidence 0001214659-14-002323 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Anthera Pharmaceuticals, Inc. — all facts · Operating Income